Abstract:Rationale: Metastasis and recurrence are the primary reasons for the high mortality rate of human hepatocellular carcinoma (HCC) patients. However, the exact mechanism underlying HCC metastasis remains unclear. The Homeobox (HOX) family proteins, which are a highly conserved transcription factor superfamily, play important roles in cancer metastasis. Here, we report a novel role of HOXC10, one of the most upregulated HOX genes in human HCC tissues, in promoting HCC metastasis. Methods: The expression of HOXC10 and its functional targets was detected by immunohistochemistry in two independent human HCC cohorts. Luciferase reporter and chromatin immunoprecipitation assays were used to measure the transcriptional regulation of target genes by HOXC10. The effect of HOXC10-mediated invasion and metastasis were analyzed by Transwell assays and by an orthotopic metastasis model. Results: Elevated expression of HOXC10 was positively correlated with the loss of tumor encapsulation and with higher tumor-nodule-metastasis (TNM) stage and poor prognosis in human HCC. Overexpression of HOXC10 promoted HCC metastasis by upregulating metastasis-related genes, including 3-phosphoinositide-dependent protein kinase 1 (PDPK1) and vasodilator-stimulated phosphoprotein (VASP). Knockdown of PDPK1 and VASP inhibited HOXC10-enhanced HCC metastasis, whereas upregulation of PDPK1 and VASP rescued the decreased metastasis induced by HOXC10 knockdown. Interleukin-1 beta (IL-1 beta), which is the ligand of IL-1R1, upregulated HOXC10 expression through the c-Jun NH2-terminal kinase (JNK)/c-Jun pathway. HOXC10 knockdown significantly reduced IL-1 beta-mediated HCC metastasis. Furthermore, Anakinra, a specific antagonist of IL-1R1, inhibited IL-1 beta-induced HOXC10 upregulation and HCC metastasis. In human HCC tissues, HOXC10 expression was positively correlated with PDPK1, VASP and IL-1R1 expression, and patients with positive coexpression of HOXC10/PDPK1, HOXC10/VASP or IL-1R1/HOXC10 exhibited the poorest prognosis. Conclusions: Upregulated HOXC10 induced by IL-1 beta promotes HCC metastasis by transactivating PDPK1 and VASP expression. Thus, our study implicates HOXC10 as a prognostic biomarker, and targeting this pathway may be a promising therapeutic option for the clinical prevention of HCC metastasis.

HOXC10 Promotes Tumour Metastasis by Regulating the EMT-related Gene Slug in Ovarian Cancer

HOXC10 Promotes Migration and Invasion Via the WNT-EMT Signaling Pathway in Oral Squamous Cell Carcinoma.

Gene Expression Profile Analysis of the Molecular Mechanism of HOXD10 Regulation of Epithelial Ovarian Cancer Cells

MicroRNA‑665 Suppresses the Growth and Migration of Ovarian Cancer Cells by Targeting HOXA10

Hoxc10 Promotes Cell Migration, Invasion, And Tumor Growth In Gastric Carcinoma Cells Through Upregulating Proinflammatory Cytokines

HOXC10 Promotes Proliferation and Invasion and Induces Immunosuppressive Gene Expression in Glioma

HOXA10 mediates epithelial-mesenchymal transition to promote gastric cancer metastasis partly via modulation of TGFB2/Smad/METTL3 signaling axis

HMOX1: A pivotal regulator of prognosis and immune dynamics in ovarian cancer

INTERLEUKIN 1-MEDIATED HOXC10 OVEREXPRESSION PROMOTES HEPATOCELLULAR CARCINOMA METASTASIS BY UPREGULATING PDPK1 AND VASP

MiR-501 Promotes Tumor Proliferation and Metastasis by Targeting HOXD10 in Endometrial Cancer

Overexpression of HOXC8 is Associated With Poor Prognosis in Epithelial Ovarian Cancer

Interleukin 1β-mediated HOXC10 Overexpression Promotes Hepatocellular Carcinoma Metastasis by Upregulating PDPK1 and VASP

MicroRNA-10b Promotes Migration and Invasion Through Hoxd10 in Human Gastric Cancer

Long Non‐coding RNA SNHG1 Stimulates Ovarian Cancer Progression by Modulating Expression of Mir‐454 and ZEB1

CXCL12-mediated HOXB5 Overexpression Facilitates Colorectal Cancer Metastasis Through Transactivating CXCR4 and ITGB3

The long non-coding RNA HOXA11-AS promotes epithelial mesenchymal transition by sponging miR-149-3p in Colorectal Cancer

HOXC10 Promotes Carboplatin Resistance of Ovarian Cancer by Regulating ABCC3.

HOXB4 Promotes the Malignant Progression of Ovarian Cancer Via DHDDS

Upregulation of HOXA10 Protein Expression Predicts Poor Prognosis for Colorectal Cancer.

MiR-135a Functions As a Tumor Suppressor in Epithelial Ovarian Cancer and Regulates HOXA10 Expression.

HOXA10 is Overexpressed in Human Ovarian Clear Cell Adenocarcinoma and Correlates with Poor Survival.